+ All Categories
Home > Documents > Barrot H. Lambdin, PhD, MPH Director of Implementation Science Pangaea Global AIDS Foundation

Barrot H. Lambdin, PhD, MPH Director of Implementation Science Pangaea Global AIDS Foundation

Date post: 22-Feb-2016
Category:
Upload: lore
View: 35 times
Download: 0 times
Share this document with a friend
Description:
Barrot H. Lambdin, PhD, MPH Director of Implementation Science Pangaea Global AIDS Foundation. Integration of HIV Treatment in Primary Health Care Centers Impacts Attrition from HIV Treatment Programs in Central Mozambique. Advancing the health and well-being of people most affected by AIDS. - PowerPoint PPT Presentation
Popular Tags:
13
Slide Title Body copy for the slide; level one content Level 1 content Level 2 content Level 3 content Barrot H. Lambdin, PhD, MPH Director of Implementation Science Pangaea Global AIDS Foundation Integration of HIV Treatment in Primary Health Care Centers Impacts Attrition from HIV Treatment Programs in Central Mozambique Advancing the health and well-being of people most affected by AIDS
Transcript
Page 1: Barrot H. Lambdin, PhD, MPH Director of Implementation Science Pangaea Global AIDS Foundation

Slide TitleBody copy for the

slide; level one content

• Level 1 content• Level 2 content• Level 3 content

Barrot H. Lambdin, PhD, MPHDirector of Implementation SciencePangaea Global AIDS Foundation

Integration of HIV Treatment in Primary Health Care Centers Impacts Attrition from HIV Treatment Programs in Central Mozambique

Advancing the health and well-being of people most affected by AIDS

Page 2: Barrot H. Lambdin, PhD, MPH Director of Implementation Science Pangaea Global AIDS Foundation

Slide TitleBody copy for the

slide; level one content

• Level 1 content• Level 2 content• Level 3 content

53% Coverage

31% In RLS

0

50000

100000

150000

200000

250000

2003 2004 2005 2006 2007 2008 2009 2010

YearPatients on ART

Patients

History of ART Scale-up in Mozambique

3,314

7,45618,95

6

44,100

88,211

128,330

170,198

218,991

Page 3: Barrot H. Lambdin, PhD, MPH Director of Implementation Science Pangaea Global AIDS Foundation

Slide TitleBody copy for the

slide; level one content

• Level 1 content• Level 2 content• Level 3 content

53% Coverage

31% In RLS

13 24 40

149

211 213222 229

0

50000

100000

150000

200000

250000

-

60

120

180

240

2003 2004 2005 2006 2007 2008 2009 2010

YearPatients on ART Facilities with ART

Clinics

Patients

National ART Program

ART Integrated with PHC Clinics

History of ART Scale-up in Mozambique

Page 4: Barrot H. Lambdin, PhD, MPH Director of Implementation Science Pangaea Global AIDS Foundation

Slide TitleBody copy for the

slide; level one content

• Level 1 content• Level 2 content• Level 3 content

Study Design, Setting and Population

• Retrospective cohort study of patients initiating ART in the national ART program (Jan 06–Jun 08)• Exclusion Criteria:

• <15 years of age• Transfer in • Pregnancy• Post Historical Events–Flooding & Temporary

Closure

• 18 HIV care and treatment clinics managed by MOH in Manica or Sofala Province• Standardized approach for care

delivery, patient tracing and data recording

• Routine Clinic Databases

Page 5: Barrot H. Lambdin, PhD, MPH Director of Implementation Science Pangaea Global AIDS Foundation

Slide TitleBody copy for the

slide; level one content

• Level 1 content• Level 2 content• Level 3 content

Methods

• Outcomes• Time until Attrition: Lost to Follow-up or Mortality

• Concern for Differential Misclassification• Analysis: Cox proportional hazards models

• Accounted for clinic-level clustering (robust variances)

• Pre-ART CD4 Count• Pre-ART WHO Stage• Age• Sex• Education• Year of Initiation• Pharmacy Staff

Burden

• Clinic Model: Vertical vs. Integrated

• Clinic Location: Urban vs. Rural

• Clinic Experience: 1st 6-months vs. After

• Covariates• Exposures

Page 6: Barrot H. Lambdin, PhD, MPH Director of Implementation Science Pangaea Global AIDS Foundation

Slide TitleBody copy for the

slide; level one content

• Level 1 content• Level 2 content• Level 3 content

Results: Study Population

Transferred810 Children 1,138

Pregnant 1,491

Included in Study 11,793

Initiated Treatment: 15,232

N (%) Delivery Model Vertical 3 (17%) Integrated 16

(89%) Location Urban 10

(55%) Rural 8 (45%)

• 9,120 person-years

• Attrition Rate: 39.22 per 100 py

Page 7: Barrot H. Lambdin, PhD, MPH Director of Implementation Science Pangaea Global AIDS Foundation

Slide TitleBody copy for the

slide; level one content

• Level 1 content• Level 2 content• Level 3 content

Results: Demographic Characteristics

36% In RLS

SexAge13%

39%30%

18%

≥15 to <25 ≥25 to <35≥35 to <45 ≥45

43%57%

Male Female

Page 8: Barrot H. Lambdin, PhD, MPH Director of Implementation Science Pangaea Global AIDS Foundation

Slide TitleBody copy for the

slide; level one content

• Level 1 content• Level 2 content• Level 3 content

Results: Clinical Characteristics

36% In RLS

WHO StageCD4 Count

29%

36%

18%

11%

<100≥100 – <200

26%

65%

9%

I/II III IV

Page 9: Barrot H. Lambdin, PhD, MPH Director of Implementation Science Pangaea Global AIDS Foundation

Slide TitleBody copy for the

slide; level one content

• Level 1 content• Level 2 content• Level 3 content

Results: Clinic Factors and Attrition

HR (95% CI) p-value Clinic Model Integrated [Ref] 1.00 Vertical 0.84 (0.73 –

0.97)0.015

Clinic Location Rural 1.00 Urban 0.86 (0.61 –

1.22)0.389

Clinic Experience First 6-Months 1.00 Post First 6-Months 0.72 (0.51-1.02) 0.065*adjusted for pre-ART CD4 count, WHO stage, age (with quadratic term), education, year of initiation and pharmacy staff burden

Page 10: Barrot H. Lambdin, PhD, MPH Director of Implementation Science Pangaea Global AIDS Foundation

Slide TitleBody copy for the

slide; level one content

• Level 1 content• Level 2 content• Level 3 content

Results: Clinic Factors and Attrition

.4.5

.6.7

.8.9

11.

11.

2H

azar

d R

atio

Clinic Model Clinic Location Clinic Experience

Clinic Characteristics

A Priori Analysis Reference Group 95% CI

Vertical

Integrated

Urban

Rural

Post 1st 6 Months

1st 6 Months

Page 11: Barrot H. Lambdin, PhD, MPH Director of Implementation Science Pangaea Global AIDS Foundation

Slide TitleBody copy for the

slide; level one content

• Level 1 content• Level 2 content• Level 3 content

Strengths & Limitations• Strengths

• Standardization of Protocols• Care delivery• Patient tracing• Data Recording

• High quality data

• Limitations• Observational Study• Unable to adjust for all patient and

clinic characteristics• Generalizeability

Page 12: Barrot H. Lambdin, PhD, MPH Director of Implementation Science Pangaea Global AIDS Foundation

Slide TitleBody copy for the

slide; level one content

• Level 1 content• Level 2 content• Level 3 content

Conclusions• Integrating HIV services into PHC

dramatically expanded coverage

• However, patients attending integrated clinics have a higher risk of attrition

• Need to address the obstacles patients face in the integrated setting

• Qualitative Study Theme: Dissatisfaction with Pharmacy in Integrated setting• Lower quality of service• Lack of Privacy

Page 13: Barrot H. Lambdin, PhD, MPH Director of Implementation Science Pangaea Global AIDS Foundation

Slide TitleBody copy for the

slide; level one content

• Level 1 content• Level 2 content• Level 3 content

Acknowledgements• Juvenol Amos • Luis Francisco• Fernando Baloi• Pedro Tenete• Mark Micek• James Pfeiffer• Pablo Montoya• Kenny Sherr• Alejandro Soto• Stephen Gloyd


Recommended